Evaluation of prediction models for type 2 Diabetes relapse after post-bariatric surgery remission: a post hoc analysis of 15-year follow-up data from the Swedish obese subjects (SOS) study
Preventing Digestive Discomfort Nausea, constipation, and bloating are common when starting or increasing the dose of a GLP-1
4 Moreover, Novo Nordisks recent SELECT trial demonstrated that Wegovy reduces the risk of cardiovascular events
Victoza also carries a black box warning for the risk of thyroid C-cell tumors based on animal studies, and while the development of medullary thyroid carcinoma in humans remains uncertain, this risk factor continues to be part of safety discussions
How They Work: Semaglutide is a GLP-1 receptor agonist, which means it mimics the hormone GLP-1 to slow digestion, reduce appetite, and regulate blood sugar levels
BRCA2 is a well-characterized HR mediator in metazoans 1,25,26,27